Odyssey Health (ODYY) Cash from Operations (2014 - 2026)
Odyssey Health's (ODYY) quarterly Cash from Operations came in at 318521.0 in Q2 2026, down 7861.03% year-on-year from 4104.1 in Q2 2025, and down 12.05% quarter-over-quarter from 284259.0 in Q1 2026.
Odyssey Health (ODYY) Cash from Operations (2014 - 2026) Analysis & Trends
Odyssey Health's Cash from Operations history runs 13 years deep, the most recent figure standing at 318521.0 for Q2 2026.
- On a quarterly basis, Cash from Operations fell 7861.03% year-over-year to 318521.0 in Q2 2026; TTM through Apr 2026 was 934977.0, a 157.69% decrease from a year earlier, with the FY2025 full-year figure at 347392.0, up 71.41% from the prior year.
- Cash from Operations fell to 318521.0 in Q2 2026 per ODYY's latest filing, from 284259.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1080115.0 in Q3 2022 and bottomed at 970018.0 in Q2 2022.
- The 5-year median for Cash from Operations is 216323.5 (2024), against an average of 235197.89.
- Across the five-year window, Cash from Operations jumped 251.16% in 2022 and sank 7861.03% in 2026, its largest moves.
- Year by year, Cash from Operations stood at 284707.0 in 2022, then surged by 78.96% to 59907.0 in 2023, then tumbled by 314.83% to 248514.0 in 2024, then dropped by 14.28% to 283998.0 in 2025, then decreased by 12.16% to 318521.0 in 2026.
- Per Business Quant, the three latest ODYY Cash from Operations figures stand at 318521.0 (Q2 2026), 284259.0 (Q1 2026), and 283998.0 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -318,521.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -318,521.00 |
| Apr 30, 2026 | -318,521.00 |
| Jan 31, 2026 | -284,259.00 |
| Jan 31, 2026 | -284,259.00 |
| Oct 31, 2025 | -283,998.00 |
| Oct 31, 2025 | -283,998.00 |
| Jul 31, 2025 | -48,199.00 |
| Jul 31, 2025 | -48,199.00 |
| Apr 30, 2025 | -4,001.00 |
| Apr 30, 2025 | -4,001.00 |
| Jan 31, 2025 | -46,678.00 |
| Jan 31, 2025 | -46,678.00 |
| Oct 31, 2024 | -248,514.00 |
| Oct 31, 2024 | -248,514.00 |
| Jul 31, 2024 | -63,635.00 |
| Jul 31, 2024 | -63,635.00 |
| Apr 30, 2024 | -184,133.00 |
| Apr 30, 2024 | -184,133.00 |
| Jan 31, 2024 | -907,535.00 |
| Jan 31, 2024 | -907,535.00 |